Sandoz + Fougera = 4 Topical Generics For Tolmar
This article was originally published in The Pink Sheet Daily
Executive Summary
FTC’s proposed consent agreement requires the Novartis unit to return marketing rights to calcipotriene topical solution, lidocaine-prilocaine cream and metronidazole topical gel to Tolmar Inc., as well as rights to market a future generic version of Solaraze (diclofenac sodium gel).